BioCentury
ARTICLE | Clinical News

OVA1 test regulatory update

September 27, 2010 7:00 AM UTC

Vermillion received CE Mark approval in the EU for its OVA1 Test to evaluate the likelihood that an ovarian adnexal mass is malignant or benign prior to a planned surgery. The in vitro diagnostic mult...